Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients

Title

Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients

Creator

Tyni T; Palotie A; Viinikka L; Valanne L; Salo MK; von Dobeln U; Jackson S; Wanders R; Venizelos N; Pihko H

Publisher

The Journal Of Pediatrics

Date

1997

Subject

Female; Humans; infant; Male; Mutation; Fatal Outcome; infant; Q3 Literature Search; Newborn; Lipid Metabolism; 3-Hydroxyacyl CoA Dehydrogenases/deficiency; Cardiomyopathies/etiology; Hypoglycemia/etiology; Inborn Errors/complications/diet therapy/genetics; Liver Diseases/etiology; Muscle Hypotonia/etiology; Retinal Diseases/etiology

Description

Long-chain 3-hydroxyacyl-coenzyme A (CoA) dehydrogenase is one of three enzyme activities of the mitochondrial trifunctional protein. We report the clinical findings of 13 patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. At presentation the patients had had hypoglycemia, cardiomyopathy, muscle hypotonia, and hepatomegaly during the first 2 years of life. Seven patients had recurrent metabolic crises, and six patients had a steadily progressive course. Two patients had cholestatic liver disease, which is uncommon in beta-oxidation defects. One patient had peripheral neuropathy, and six patients had retinopathy with focal pigmentary aggregations or retinal hypopigmentation. All patients were homozygous for the common mutation G1528C. However, the enoyl-CoA hydratase and 3-ketoacyl-CoA thiolase activities of the mitochondrial trifunctional protein were variably decreased in skin fibroblasts. Dicarboxylic aciduria was detected in 9 of 10 patients, and most patients had lactic acidosis, increased serum creatine kinase activities, and low serum carnitine concentration. Neuroradiologically there was bilateral periventricular or focal cortical lesions in three patients, and brain atrophy in one. Only one patient, who has had dietary treatment for 9 years, is alive at the age of 14 years; all others died before they were 2 years of age. Recognition of the clinical features of long-chain 3-hydroxyacyl-CoA deficiency is important for the early institution of dietary management, which may alter the otherwise invariably poor prognosis.
1997

Rights

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Type

Journal Article

Citation List Month

Backlog

Citation

Tyni T; Palotie A; Viinikka L; Valanne L; Salo MK; von Dobeln U; Jackson S; Wanders R; Venizelos N; Pihko H, “Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients,” Pediatric Palliative Care Library, accessed December 13, 2024, https://pedpalascnetlibrary.omeka.net/items/show/12254.